SGLT2 vs DPP4 Inhibitor: Which Protects Liver Better in T2D? ...Middle East

Medscape - News
SGLT2 inhibitors did not reduce the risk for adverse liver outcomes more than DPP-4 inhibitors in patients with type 2 diabetes and metabolic dysfunction–associated steatotic liver disease. Medscape Medical News

Hence then, the article about sglt2 vs dpp4 inhibitor which protects liver better in t2d was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SGLT2 vs DPP4 Inhibitor: Which Protects Liver Better in T2D? )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News